Pregabalin in patients with primary brain tumors and seizures: A preliminary observation

Clinical Neurology and Neurosurgery

Volumn 111, Issue 2, 2009, Pages 171-173

  Novy, Jan ^a   Stupp, Roger ^a   Rossetti, Andrea O ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Chemotherapy; Epilepsy; Interactions; Pregabalin; Primary brain tumors

Indexed keywords

CARBAMAZEPINE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; METHOTREXATE; PHENYTOIN; PREGABALIN; TEMOZOLOMIDE; VALPROIC ACID;

ADULT; ARTICLE; BRAIN TUMOR; CLINICAL ARTICLE; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EDEMA; ERECTILE DYSFUNCTION; FATIGUE; FEMALE; FOLLOW UP; GLIOBLASTOMA; GLIOMA; HUMAN; MALE; SEIZURE; TREATMENT DURATION; TREATMENT RESPONSE; TUMOR GROWTH; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; ANTICONVULSANTS; BRAIN NEOPLASMS; EPILEPSIES, PARTIAL; FEMALE; FOLLOW-UP STUDIES; GAMMA-AMINOBUTYRIC ACID; GLIOMA; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEIZURES; TREATMENT OUTCOME;

EID: 58349107236     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2008.09.009     Document Type: Article

References (25)

1. van Breemen M.S., Wilms E.B., and Vecht C.J. Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol 6 (2007) 421-430
2. Glantz M.J., Cole B.F., Forsyth P.A., Recht L.D., Wen P.Y., Chamberlain M.C., et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 54 (2000) 1886-1893
3. Hildebrand J., Lecaille C., Perennes J., and Delattre J.-Y. Epileptic seizures during follow-up of patients treated for primary brain tumors. Neurology 65 (2005) 212-215
4. Wen P.Y., Schiff D., Kesari S., Drappatz J., Gigas D.C., and Doherty L. Medical management of patients with brain tumors. J Neurooncol 80 (2006) 313-332
5. Vecht C.J., and van Breemen M. Optimizing therapy of seizures in patients with brain tumors. Neurology 67 (2006) S10-13
6. Ben-Menachem E. Pregabalin pharmacology and its relevance to clinical practice. Epilepsia 45 Suppl. 6 (2004) 13-18
7. Fisher R.S., van Emde Boas W., Blume W., Elger C., Genton P., Lee P., et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 46 (2005) 470-472
8. Cavaliere R., Wen P.Y., and Schiff D. Novel therapies for malignant gliomas. Neurol Clin 25 (2007) 1141-1171
9. Relling M.V., Pui C.H., Sandlund J.T., Rivera G.K., Hancock M.L., Boyett J.M., et al. Adverse effect of anticonvulsants on efficacy of chemotherapy for acute lymphoblastic leukaemia. Lancet 356 (2000) 285-290
10. Vera K., Djafari L., Faivre S., Guillamo J.S., Djazouli K., Osorio M., et al. Dose-dense regimen of temozolomide given every other week in patients with primary central nervous system tumors. Ann Oncol 15 (2004) 161-171
11. Bourg V., Lebrun C., Chichmanian R.M., Thomas P., and Frenay M. Nitroso-urea-cisplatin-based chemotherapy associated with valproate: increase of haematologic toxicity. Ann Oncol 12 (2001) 217-219
12. Maschio M., Dinapoli L., Zarabla A., Pompili A., Carapella C.M., Pace A., et al. Outcome and tolerability of topiramate in brain tumor associated epilepsy. J Neurooncol 86 (2008) 61-70
13. Perry J.R., and Sawka C. Add-on gabapentin for refractory seizures in patients with brain tumours. Can J Neurol Sci 23 (1996) 128-131
14. Newton H.B., Goldlust S.A., and Pearl D. Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients. J Neurooncol 78 (2006) 99-102
15. Meador K.J., Loring D.W., Vahle V.J., Ray P.G., Werz M.A., Fessler A.J., et al. Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers. Neurology 64 (2005) 2108-2114
16. Benedetti M.S. Enzyme induction and inhibition by new antiepileptic drugs: a review of human studies. Fundam Clin Pharmacol 14 (2000) 301-319
17. Perucca E. The clinical pharmacokinetics of the new antiepileptic drugs. Epilepsia 40 (1999) S7-S13
18. Hirsch L.J., Arif H., Buchsbaum R., Weintraub D., Lee J., Chang J.T., et al. Effect of age and comedication on levetiracetam pharmacokinetics and tolerability. Epilepsia 48 (2007) 1351-1359
19. Brodie M.J., Wilson E.A., Wesche D.L., Alvey C.W., Randinitis E.J., Posvar E.L., et al. Pregabalin drug interaction studies: lack of effect on the pharmacokinetics of carbamazepine, phenytoin, lamotrigine, and valproate in patients with partial epilepsy. Epilepsia 46 (2005) 1407-1413
20. Maschio M., Albani F., Baruzzi A., Zarabla A., Dinapoli L., Pace A., et al. Levetiracetam therapy in patients with brain tumour and epilepsy. J Neurooncol 80 (2006) 97-100
21. Wagner G.L., Wilms E.B., Van Donselaar C.A., and Vecht Ch J. Levetiracetam: preliminary experience in patients with primary brain tumours. Seizure 12 (2003) 585-586
22. Mula M., Trimble M.R., Yuen A., Liu R.S.N., and Sander J.W.A.S. Psychiatric adverse events during levetiracetam therapy. Neurology 61 (2003) 704-706
23. Elger C.E., Brodie M.J., Anhut H., Lee C.M., and Barrett J.A. Pregabalin add-on treatment in patients with partial seizures: a novel evaluation of flexible-dose and fixed-dose treatment in a double-blind, placebo-controlled study. Epilepsia 46 (2005) 1926-1936
24. Arroyo S., Anhut H., Kugler A.R., Lee C.M., Knapp L.E., Garofalo E.A., et al. Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures. Epilepsia 45 (2004) 20-27
25. Carreno M., Maestro I., Molins A., Donaire A., Falip M., Becerra J.L., et al. Pregabalin as add-on therapy for refractory partial seizures in every day clinical practice. Seizure 16 (2007) 709-712